Comment on Everything you need to know about GLP-1s for weight loss by Christopher Newbury
Under the section “are weight loss jabs available on the NHS” you have not mentioned TA1152 ( where nice recommends semaglutide for use in cardiovascular secondary prevention. The only criteria for this indication is previous stroke (haemorrhagic or ischaemic) or myocardial infarction or peripheral vascular disease together with a BMI over 27 ICBs have 90 da
Comments for The Pharmaceutical Journal6d ago 
